A new compound that halts the progression of Alzheimer's disease by interfering with the role amyloid-a has been discovered by scientists. For more than a decade, potential Alzheimer's drugs have targeted amyloid-a, but, in clinical trials, they have either failed to slow the progression of the disease or caused serious side effects. However, by targeting the protein's ability to bind to a clotting agent in blood, the work in the Strickland lab offers ...
Read More
No comments:
Post a Comment